Basic information
Biomarker: MIB1
Histology type: endometrial stromal tumor
Stage: low-grade,stage I
Cohort characteristics
Country: USA
Region: NY
Study type: Case Reports
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
11 | LESS | 11 |
Sample information
Conclusion: MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : positive expression
Expression elevation: MIB1 positivity (defined as a MIB1 reactivity score> 5%)
Disease information
Statictics: Mean ;Range
Cohort age: 43.8;27-76
Related information
Funtion Uniprot: E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors. Probably mediates ubiquitination and subsequent proteasomal degradation of DAPK1, thereby antagonizing anti-apoptotic effects of DAPK1 to promote TNF-induced apoptosis (By similarity). Involved in ubiquitination of centriolar satellite CEP131, CEP290 and PCM1 proteins and hence inhibits primary cilium formation in proliferating cells. Mediates 'Lys-63'-linked polyubiquitination of TBK1, which probably participates in kinase activation
UniProt ID: Q86YT6
UniProt Link: https://www.uniprot.org/uniprotkb/Q86YT6/entry
Biological function from UniProt: #Notch signaling pathway #Ubl conjugation pathway
Molecular function from UniProt:
Tissue specificity from UniProt: Widely expressed at low level. Expressed at higher level in spinal cord, ovary, whole brain, and all specific brain regions examined.
Subcellular UniProt: #Cell membrane #Cytoplasm #Cytoskeleton #Membrane
Alternative name from UniProt:
Miscellaneous: In epilepsy brain tissue, levels of expression are increased in the cytoplasm and microsomal fractions (endoplasmic reticulum).
Catalytic activity: S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6-ubiquitinyl-[acceptor protein]-L-lysine.
Recommended name: E3 ubiquitin-protein ligase MIB1
Gene name from HGNC: MIB1 (DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6) Tissue specificityi Low tissue specificity
HPA class: Disease related genes Enzymes Human disease related genes Metabolic proteins Potential drug targets
AlphaFold DB: Q86YT6
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/Q86YT6
HPA link: https://www.proteinatlas.org/ENSG00000101752-MIB1
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Cytoplasmic expression in many tissues.
Single cell type specificity Cell type enhanced (Oligodendrocyte precursor cells, Oligodendrocytes)
Immune cell specificity: Not detected in immune cells
Subcellular summary HPA Located in Vesicles, Plasma membrane
Cancer prognostic summary HPA Gene product is not prognostic
Pathology link: https://www.proteinatlas.org/ENSG00000101752-MIB1/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000101752-MIB1/pathology/endometrial+cancer
Phenotype ID: 615092
Disease: Left ventricular non-compaction 7 (LVNC7)
Note1: The disease is caused by variants affecting the gene represented in this entry;
OMIM link1: https://www.omim.org/entry/615092
HGNC ID: HGNC:21086
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:21086